Effect of Rosuvastatin Combined with Valsartan in the Treatment of Coronary Heart Disease and the Impact on Glucose and Lipid Metabolism
Objective To explore the effect of rosuvastatin combined with valsartan in the treatment of coronary heart disease(CHD)and the impact on glucose and lipid metabolism.Methods 98 CHD patients admitted to our hospital from October 2020 to October 2023 were divided into two groups according to parity order.The control group was treated with valsartan,and the observation group was treated with valsartan combined with rosuvastatin.The plaque area,glucose and lipid metabolism indicators,and cardiac function indicators were compared between the two groups.Results After treatment,the area of lipid,calcification and mixed plaque in the observation group were lower than those in the control group(P＜0.05).After treatment,the TG,LDL-C,FPG and HbA1c levels of the observation group were lower than those of the control group(P＜0.05).After treatment,the BNP of the observation group was lower than that of control group,and the LVEF was higher than that of the control group(P＜0.05).Conclusions Rosuvastatin combined with valsartan has exact effect in the treatment of CHD,which can reduce the coronary plaque area,regulate the glucose and lipid metabolism,and improve the cardiac function.
国家科技期刊平台
NSTL
万方数据
